Acusphere, in partnership with Nycomed, approached Origin to develop a name for their unique contrast agent, for use with ultrasound devices in the detection of coronary heart disease.

After exploring a variety of name types and strategies, the name Imagify was chosen to express the enlarged potential of the new product, as well as its functional benefits.